Date | Insider | Price | Amount |
---|---|---|---|
6-29-2022 Insider Buy |
Seth Lederman Chief Executive Officer |
$1.71 CAGR » |
$34,200.00 20,000 shares |
3-25-2022 Insider Buy |
Seth Lederman Chief Executive Officer |
$0.24 CAGR » |
$24,500.00 100,000 shares |
9-28-2021 Insider Buy |
Seth Lederman Chief Executive Officer |
$0.61 CAGR » |
$7,320.00 12,000 shares |
5-25-2021 Insider Buy |
Daniel Wintner Goodman Director |
$1.12 CAGR » |
$5,600.00 5,000 shares |
3-24-2021 Insider Buy |
Seth Lederman Chief Executive Officer |
$1.32 CAGR » |
$22,087.56 16,733 shares |
8-31-2020 Insider Buy |
James Treco Director |
$0.89 CAGR » |
$4,895.00 5,500 shares |
8-20-2020 Insider Buy |
Margaret Smith Bell Director |
$0.93 CAGR » |
$4,997.46 5,391 shares |
8-17-2020 Insider Buy |
Gregory M. Sullivan Chief Medical Officer |
$1.03 CAGR » |
$20,600.00 20,000 shares |
8-13-2020 Insider Buy |
Richard H. Bagger Director |
$0.91 CAGR » |
$9,100.00 10,000 shares |
8-13-2020 Insider Buy |
Seth Lederman Chief Executive Officer |
$0.91 CAGR » |
$54,600.00 60,000 shares |
8-13-2020 Insider Buy |
Adeoye Y. Olukotun Director |
$0.94 CAGR » |
$5,029.00 5,350 shares |
8-14-2020 Insider Buy |
James Treco Director |
$1.06 CAGR » |
$4,770.00 4,500 shares |
12-3-2019 Insider Buy |
Seth Lederman Chief Executive Officer |
$1.16 CAGR » |
$23,180.00 20,000 shares |
3-29-2019 Insider Buy |
Seth Lederman Chief Executive Officer |
$2.49 CAGR » |
$12,440.00 5,000 shares |
3-26-2019 Insider Buy |
Seth Lederman Chief Executive Officer |
$2.38 CAGR » |
$59,375.00 25,000 shares |
6-28-2018 Insider Buy |
Seth Lederman Chief Executive Officer |
$4.58 CAGR » |
$2,290.00 500 shares |
6-27-2018 Insider Buy |
Seth Lederman Chief Executive Officer |
$4.55 CAGR » |
$2,275.00 500 shares |
6-25-2018 Insider Buy |
Ernest Mario Director |
$4.48 CAGR » |
$73,920.00 16,500 shares |
6-14-2018 Insider Buy |
Gregory M. Sullivan Chief Medical Officer |
$3.96 CAGR » |
$39,650.00 10,000 shares |
6-1-2018 Insider Buy |
John B. Rhodes Director |
$3.33 CAGR » |
$24,975.00 7,500 shares |
5-25-2018 Insider Buy |
Seth Lederman Chief Executive Officer |
$3.17 CAGR » |
$12,680.00 4,000 shares |
12-26-2017 Insider Buy |
Seth Lederman Chief Executive Officer |
$3.61 CAGR » |
$19,133.00 5,300 shares |
8-17-2017 Insider Buy |
Seth Lederman Chief Executive Officer |
$3.00 CAGR » |
$60,017.50 20,000 shares |
6-30-2017 Insider Buy |
Seth Lederman Chief Executive Officer |
$4.33 CAGR » |
$21,640.00 5,000 shares |
6-26-2017 Insider Buy |
Seth Lederman Chief Executive Officer |
$4.40 CAGR » |
$21,999.50 5,000 shares |
6-20-2017 Insider Buy |
Seth Lederman Chief Executive Officer |
$4.22 CAGR » |
$84,400.00 20,000 shares |
11-23-2016 Insider Buy |
Ernest Mario Director |
$0.41 CAGR » |
$48,600.00 120,000 shares |
11-21-2016 Insider Buy |
Seth Lederman Chief Executive Officer |
$0.43 CAGR » |
$41,924.40 98,000 shares |
9-13-2016 Insider Buy |
Ernest Mario Director |
$0.79 CAGR » |
$79,180.00 100,000 shares |
6-21-2016 Insider Buy |
Samuel R. Saks Director |
$2.00 CAGR » |
$25,000.00 12,500 shares |
6-22-2016 Insider Buy |
Seth Lederman Chief Executive Officer |
$2.08 CAGR » |
$41,500.00 20,000 shares |
6-21-2016 Insider Buy |
Bruce Daugherty See remarks |
$2.00 CAGR » |
$200,000.00 100,000 shares |
6-21-2016 Insider Buy |
John B. Rhodes Director |
$2.00 CAGR » |
$50,000.00 25,000 shares |
6-21-2016 Insider Buy |
Seth Lederman Chief Executive Officer |
$2.00 CAGR » |
$50,000.00 25,000 shares |
6-21-2016 Insider Buy |
Ernest Mario Director |
$2.00 CAGR » |
$100,000.00 50,000 shares |
6-21-2016 Insider Buy |
Bradley Saenger Chief Financial Officer |
$2.00 CAGR » |
$4,000.00 2,000 shares |
6-3-2016 Insider Buy |
Gregory M. Sullivan Chief Medical Officer |
$2.50 CAGR » |
$49,916.00 20,000 shares |
5-12-2016 Insider Buy |
Ernest Mario Director |
$2.30 CAGR » |
$71,356.25 31,042 shares |
5-11-2016 Insider Buy |
Ernest Mario Director |
$2.24 CAGR » |
$18,399.43 8,210 shares |
3-23-2016 Insider Buy |
Seth Lederman Chief Executive Officer |
$2.44 CAGR » |
$19,536.80 8,000 shares |
3-16-2016 Insider Buy |
Ernest Mario Director |
$2.29 CAGR » |
$171,712.50 75,000 shares |
9-28-2015 Insider Buy |
Gregory M. Sullivan Chief Medical Officer |
$5.95 CAGR » |
$27,925.08 4,694 shares |
9-28-2015 Insider Buy |
Leland Gershell Chief Financial Officer |
$5.83 CAGR » |
$2,330.00 400 shares |
9-28-2015 Insider Buy |
Gregory M. Sullivan Chief Medical Officer |
$5.95 CAGR » |
$27,925.08 4,694 shares |
9-25-2015 Insider Buy |
Seth Lederman Chief Executive Officer |
$6.50 CAGR » |
$39,000.00 6,000 shares |
8-26-2015 Insider Buy |
Ernest Mario Director |
$6.05 CAGR » |
$60,500.00 10,000 shares |
8-25-2015 Insider Buy |
Ernest Mario Director |
$6.40 CAGR » |
$9,395.20 1,468 shares |
8-24-2015 Insider Buy |
Ernest Mario Director |
$6.20 CAGR » |
$15,698.40 2,532 shares |
8-20-2015 Insider Buy |
Ernest Mario Director |
$6.64 CAGR » |
$39,867.00 6,000 shares |
8-17-2015 Insider Buy |
Ernest Mario Director |
$6.93 CAGR » |
$104,017.50 15,000 shares |
7-17-2015 Insider Buy |
Seth Lederman Chief Executive Officer |
$7.50 CAGR » |
$45,000.00 6,000 shares |
7-17-2015 Insider Buy |
John B. Rhodes Director |
$7.50 CAGR » |
$45,000.00 6,000 shares |
7-17-2015 Insider Buy |
Samuel R. Saks Director |
$7.50 CAGR » |
$75,000.00 10,000 shares |
7-17-2015 Insider Buy |
Leland Gershell Chief Financial Officer |
$7.50 CAGR » |
$7,500.00 1,000 shares |
7-17-2015 Insider Buy |
Ernest Mario Director |
$7.50 CAGR » |
$187,500.00 25,000 shares |
6-11-2015 Insider Buy |
Gregory M. Sullivan Chief Medical Officer |
$8.38 CAGR » |
$37,710.00 4,500 shares |
3-17-2015 Insider Buy |
Seth Lederman Chief Executive Officer |
$7.02 CAGR » |
$14,033.30 2,000 shares |
3-13-2015 Insider Buy |
Seth Lederman Chief Executive Officer |
$7.24 CAGR » |
$14,470.00 2,000 shares |
3-11-2015 Insider Buy |
Seth Lederman Chief Executive Officer |
$6.95 CAGR » |
$13,900.00 2,000 shares |
3-10-2015 Insider Buy |
Charles E. Mather IV Director |
$6.80 CAGR » |
$6,800.00 1,000 shares |
3-9-2015 Insider Buy |
Seth Lederman Chief Executive Officer |
$6.47 CAGR » |
$12,950.00 2,000 shares |
3-6-2015 Insider Buy |
Ernest Mario Director |
$6.57 CAGR » |
$26,279.60 4,000 shares |
3-5-2015 Insider Buy |
Seth Lederman Chief Executive Officer |
$6.26 CAGR » |
$12,530.00 2,000 shares |
2-9-2015 Insider Buy |
Ernest Mario Director |
$5.85 CAGR » |
$175,500.00 30,000 shares |
2-9-2015 Insider Buy |
Leland Gershell Chief Financial Officer |
$5.85 CAGR » |
$29,250.00 5,000 shares |
2-9-2015 Insider Buy |
Seth Lederman Chief Executive Officer |
$5.85 CAGR » |
$29,250.00 5,000 shares |
9-27-2013 Insider Buy |
Charles E. Mather IV Director |
$3.65 CAGR » |
$3,650.00 1,000 shares |
9-9-2013 Insider Buy |
Charles E. Mather IV Director |
$3.48 CAGR » |
$2,088.00 600 shares |
9-6-2013 Insider Buy |
Leland Gershell CFO and Treasurer |
$3.40 CAGR » |
$1,700.00 500 shares |
9-4-2013 Insider Buy |
Charles E. Mather IV Director |
$3.23 CAGR » |
$1,456.73 451 shares |
5-31-2013 Insider Buy |
Bruce Daugherty SEE REMARKS |
$6.95 CAGR » |
$695.00 100 shares |
5-29-2013 Insider Buy |
Bruce Daugherty SEE REMARKS |
$7.25 CAGR » |
$725.00 100 shares |
5-24-2013 Insider Buy |
Leland Gershell CFO and Treasurer |
$7.49 CAGR » |
$1,498.00 200 shares |
5-24-2013 Insider Buy |
Bruce Daugherty SEE REMARKS |
$7.47 CAGR » |
$747.00 100 shares |
5-22-2013 Insider Buy |
Bruce Daugherty See Remarks |
$7.48 CAGR » |
$1,496.00 200 shares |
5-21-2013 Insider Buy |
Leland Gershell CFO and Treasurer |
$7.49 CAGR » |
$749.00 100 shares |
5-20-2013 Insider Buy |
Seth Lederman Chief Executive Officer |
$7.30 CAGR » |
$7,300.00 1,000 shares |
Also See: Institutional Holders of TNXP
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 06/30/2022 | |
End date: | 04/26/2024 | |
Start price/share: | $1.58 | |
End price/share: | $0.17 | |
Dividends collected/share: | $0.00 | |
Total return: | -89.24% | |
Average Annual Total Return: | -70.53% | |
Starting investment: | $10,000.00 | |
Ending investment: | $1,075.97 | |
Years: | 1.82 |
TNXP Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent TNXP insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding TNXP
Free TNXP Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the TNXP Insider Buying occurred are:
IVC Insider Buying |